CS Interpharm and CS Diagnostics Pharma, have successfully completed the conversion of their holdings in the Company's Series B Preferred Stock into unrestricted common stock. This milestone marks a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback